Does Rallies show 13F holders for RVTY?

Yes. Rallies tracks hedge fund and 13F ownership data for RVTY, including fund names, share counts, latest tracked quarter, and position changes when available.

Is RVTY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RVTY. It does not provide personalized investment advice.

RVTY (Revvity, Inc.) Stock Analysis - Hedge Fund Holdings

Revvity, Inc. (RVTY) is a publicly traded Healthcare sector company. As of May 21, 2026, RVTY trades at $94.89 with a market cap of $10.65B and a P/E ratio of 46.01. RVTY moved -0.97% today. Year to date, RVTY is -7.11%; over the trailing twelve months it is +1.30%. Its 52-week range spans $81.22 to $129.50. Analyst consensus is buy with an average price target of $104.75. Rallies surfaces RVTY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns RVTY stock?

Hedge funds tracked by Rallies that own RVTY include Bridgewater Associates, Pinebridge Investments, Panagora Asset, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Revvity, Inc..

RVTY Key Metrics

Key financial metrics for RVTY
Metric	Value
Price	$94.89
Market Cap	$10.65B
P/E Ratio	46.01
EPS	$2.07
Dividend Yield	0.07%
52-Week High	$129.50
52-Week Low	$81.22
Volume	1.05M
Avg Volume	0
Revenue (TTM)	$2.86B
Net Income	$241.20M
Gross Margin	0.00%

Top Hedge Funds Holding RVTY

Bridgewater Associates holds 37.06K shares of RVTY, changed +1654.09% as of Mar 31, 2026.
Pinebridge Investments holds 14.52K shares of RVTY, changed -8.07% as of Sep 30, 2024.
Panagora Asset holds 3.25K shares of RVTY, changed +0.00% as of Mar 31, 2026.
Centerbook Partners holds 2.81K shares of RVTY, changed +0.00% as of Mar 31, 2026.

Latest RVTY News

Revvity jumps after Q1 EPS beat as investors look past lowered 2026 outlook — May 6, 2026
Revvity jumps as Q1 EPS beats and China immunodiagnostics divestiture unveiled — May 5, 2026
Revvity jumps as Signals BioDesign launch spotlights software growth ahead of earnings — Apr 30, 2026
Revvity slides ahead of May 5 earnings as growth outlook faces scrutiny — Apr 29, 2026
Revvity drops nearly 8% as investors de-risk ahead of May 5 earnings — Apr 23, 2026

Recent RVTY Insider Trades

Gonzales Anita sold 80 (~$7.42K) on Apr 20, 2026.
Victor Miriame sold 1.86K (~$180.86K) on Feb 24, 2026.
McMurry-Heath Michelle sold 600 (~$58.36K) on Feb 23, 2026.

RVTY Analyst Consensus

10 analysts cover RVTY: 0 strong buy, 3 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $104.75.

Common questions about RVTY

Who owns RVTY stock?: Hedge funds tracked by Rallies that own RVTY include Bridgewater Associates, Pinebridge Investments, Panagora Asset, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Revvity, Inc..
Does Rallies show 13F holders for RVTY?: Yes. Rallies tracks hedge fund and 13F ownership data for RVTY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is RVTY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RVTY. It does not provide personalized investment advice.